๐ฐ Asserted Claims News
Asserted Claims News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Asserted Claims. Real-time updates on events, politics, business and more.
September 25, 2023
We previously reported on patent infringement litigations between Alnylam and Moderna. Below we provide updates on two proceedings involving the mRNA vaccine producer Moderna.
September 22, 2023
โโโโโโโWe previously reported on patent infringement litigations between Alnylam and Moderna. Below we provide updates on two proceedings involving the mRNA vaccine producer Moderna.
April 5, 2023
On March 24, 2023, Judge John P. Cronan found the asserted claims of two patents to be directed to abstract ideas under 35 U.S.C. § 101, but suaโฆ
April 5, 2023
On March 24, 2023, Judge John P. Cronan found the asserted claims of two patents to be directed to abstract ideas under 35 U.S.C. § 101, but sua sponte granted leave to amend the...
March 24, 2023
Barely two weeks ago on March 10th, Charlie Ergenโs DBS DISH Network lost a Utah jury verdict on a patent lawsuit with plaintiff ClearPlay. The verdict saw th
March 13, 2023
Judge Albright dismissed Plaintiff Fare Technologies LLC's complaint against Lyft, Inc. for failure to plead that Defendant has a server in W.D. Tex. that could comprise the "computer" of the asserted...
February 28, 2023
On October 17, 2022, Justice St-Louis of the Federal Court granted a motion for summary trial brought by Teva, Pharmascience, Laboratoire Riva, Apotex and Mylan (the Defendants) and...
June 28, 2022
On May 31, 2022, the Federal Court released a decision by Justice Pallotta in a patent infringement action pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance)...
June 27, 2022
A few months ago, we explored ideas for defendants who wished to quickly dispense with lawsuits involving patents directed to patent ineligible subject matter like abstract ideas or laws of nature.
April 9, 2022
- Jury Upholds Validity of Asserted Claims of the Patent, Finds Willful Infringement and Issues Past Damages Award of $41.82 Million -- Seagen to Request Royalty on Future U.S. Sales of Enhertu® Through the Life of the Patent -- Separate Arbitration Proceedings with Daiichi Sankyo Remain Ongoing with a Decision Expe...